Charlotte, North Carolina, Bristol, Tennessee and London, Ontario, Canada – (March 30, 2004) – SJ Pharmaceuticals, Inc. (“SJ”) of Bristol, Tennessee recently announced that they have signed Supply and License Agreements with Stellar International, Inc. (“Stellar”) for NeoVisc® and Uracyst® in the United States markets. Bourne Partners initiated and advised SJ on the transaction.
